One of the oldest pharmaceuticals company GlaxoSmithKline Pharmaceuticals Ltd. was established in the year 1924 in India. It is a British multinational pharmaceutical company headquartered in Brentford, London. GSK was the world’s sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome (formed from Glaxo’s 1995 acquisition of Burroughs Wellcome) and SmithKline Beecham (from the 1989 merger of the Beecham Group and the SmithKline Beckman Corporation). As of 6 May 2015 it had a market capitalisation of £73 billion, the fourth-largest of any company listed on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange. Andrew Witty has been the chief executive officer since May 2008.
GSK has a portfolio of products for major disease areas such as asthma, cancer, infections, mental health, diabetes and digestive conditions. Its drugs and vaccines earned £21.3 billion in 2013. The company applied for regulatory approval in 2014 for the first malaria vaccine, RTS,S, which it plans to make available for five percent above cost. GSK’s consumer healthcare products, which earned £5.2 billion in 2013, include Sensodyne and Aquafresh toothpaste, the malted-milk drink Horlicks, Abreva for cold sores, Breathe Right nasal strips, Nicoderm and Nicorette nicotine replacements, and Night Nurse, a cold remedy.
- Lamictal and many more
|Traded as||LSE: GSK
|Industry||Pharmaceutical, Biotechnology, Consumer goods|
New York City, US
|Key people||Gerald Grosvenor, Philip Hampton (Chairman)
Andrew Witty (CEO)
|Products||Pharmaceuticals, vaccines, oral healthcare products, nutritional products, over-the-counter medicines|
|Revenue||£23.006 billion (2014)|
|Net income||£2.831 billion (2014)|
|Number of employees||96,575 (2015)|